Two studies presented in March at #ACC19 are the talk of the cardiology community. Both address one question: Can low-risk patients with aortic stenosis benefit from TAVR? Dharam Kumbhani, M.D., says the data are intriguing, but the excitement is a bit premature. Learn more.
MitraClip has emerged as a treatment option for patients with mitral valve disease who are not healthy enough for valve replacement surgery. However, the device is approved for only a small patient pool – and it might be unnecessary with optimized medical therapy.
